Barclays Initiates Coverage On First Advantage with Overweight Rating, Announces Price Target of $24
Barclays initiates coverage on First Advantage (NASDAQ:FA) with a Overweight rating and announces Price Target of $24.
RBC Capital Initiates Coverage On Bright Health Gr with Outperform Rating, Announces Price Target of $22
RBC Capital analyst Frank Morgan initiates coverage on Bright Health Gr (NYSE:BHG) with a Outperform rating and announces Price Target of $22.
RBC Capital Initiates Coverage On First Advantage with Outperform Rating, Announces Price Target of $22
RBC Capital analyst Ashish Sabadra initiates coverage on First Advantage (NASDAQ:FA) with a Outperform rating and announces Price Target of $22.
Citigroup Initiates Coverage On Bright Health Gr with Neutral Rating, Announces Price Target of $16
Citigroup initiates coverage on Bright Health Gr (NYSE:BHG) with a Neutral rating and announces Price Target of $16.
JP Morgan Initiates Coverage On Sprinklr with Neutral Rating, Announces Price Target of $21
JP Morgan analyst Mark Murphy initiates coverage on Sprinklr (NYSE:CXM) with a Neutral rating and announces Price Target of $21.
Piper Sandler Initiates Coverage On Confluent with Overweight Rating, Announces Price Target of $50
Piper Sandler analyst Rob Owens initiates coverage on Confluent (NASDAQ:CFLT) with a Overweight rating and announces Price Target of $50.
Keybanc Initiates Coverage On Confluent with Sector Weight Rating
Keybanc analyst Michael Turits initiates coverage on Confluent (NASDAQ:CFLT) with a Sector Weight rating.
Piper Sandler Initiates Coverage On Ameresco with Overweight Rating, Announces Price Target of $77
Piper Sandler analyst Pearce Hammond initiates coverage on Ameresco (NYSE:AMRC) with a Overweight rating and announces Price Target of $77.
Piper Sandler Initiates Coverage On Bright Health Gr with Overweight Rating, Announces Price Target of $24
Piper Sandler analyst Jeff Garro initiates coverage on Bright Health Gr (NYSE:BHG) with a Overweight rating and announces Price Target of $24.
Keybanc Initiates Coverage On Sprinklr with Overweight Rating, Announces Price Target of $26
Keybanc analyst Michael Turits initiates coverage on Sprinklr (NYSE:CXM) with a Overweight rating and announces Price Target of $26.